Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.640
-0.010 (-0.27%)
At close: Feb 13, 2026, 4:00 PM EST
3.730
+0.090 (2.47%)
After-hours: Feb 13, 2026, 7:52 PM EST

Quantum BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
14736304230
Market Cap Growth
144.27%-80.54%20.93%-29.85%40.95%-30.30%
Enterprise Value
140326316
Last Close Price
3.643.6859.7951.2566.30101.40
PB Ratio
1.850.672.770.970.780.82
P/TBV Ratio
3.451.064.541.601.111.31
Debt / Equity Ratio
0.340.080.030.020.010.01
Net Debt / Equity Ratio
0.20-0.61-0.25-0.54-0.64-0.47
Net Debt / EBITDA Ratio
-0.080.410.190.721.170.66
Net Debt / FCF Ratio
-0.170.930.290.581.680.89
Quick Ratio
0.611.652.392.224.133.17
Current Ratio
1.411.812.432.285.284.82
Return on Equity (ROE)
-251.26%-127.76%-83.91%-63.08%-75.05%-78.40%
Return on Assets (ROA)
-72.22%-58.31%-43.02%-33.82%-40.20%-43.79%
Return on Capital Employed (ROCE)
-255.40%-154.60%-149.00%-89.70%-62.20%-82.00%
Earnings Yield
-204.98%-203.95%-50.03%-79.79%-83.66%-106.26%
FCF Yield
-63.03%-98.75%-30.26%-96.15%-49.19%-63.93%
Buyback Yield / Dilution
-256.09%-86.67%-2.21%-10.84%-190.15%-70.69%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q